. Author manuscript; available in PMC: 2013 Dec 9.

Published in final edited form as: J Sex Med. 2012 Mar 29;9(6):10.1111/j.1743-6109.2012.02708.x. doi: 10.1111/j.1743-6109.2012.02708.x

Table 3.

Means, Standard Deviations, and Correlations for the Relationship Between Changes in Endocannabinoids and Changes in Physiological and Subjective Sexual Arousal

EXPERIMENTAL CONDITION
Variables	2-AG	VPA	PHYS	MEN	OVER	CON	M	SD
AEA	.49^*	-.48^*	-.38	-.51^*	-.43^ˆ	-.60^*	-0.12	.21
2-AG	—	-.17	-.54^*	-.33	-.66^*	-.63^*	-1.22	11.23
VPA	—	—	.04	.27	.29	.46^*	52.10	101.99
PHYS	—	—	—	.55^*	.77^*	.43^ˆ	11.76	5.66
MEN	—	—	—	—	.77^*	.34	10.57	6.20
OVER	—	—	—	—	—	.61^*	2.95	1.75
CON	—	—	—	—	—	—	3.03	1.59

CONTROL CONDITION
Variables	2-AG	VPA	PHYS	MEN	OVER	CON	M	SD

AEA	.43^ˆ	-.03	.08	.25	-.00	-.26	-0.03	.30
2-AG	—	-.43^ˆ	-.12	-.32	-.10	-.40	-4.17	11.62
VPA	—	—	-.11	.23	-.34	-.18	-1.25	18.36
PHYS	—	—	—	.30	.93^*	.15	-0.14	4.33
MEN	—	—	—	—	.25	.03	-2.05	2.58
OVER	—	—	—	—	—	.24	-0.05	1.07
CON	—	—	—	—	—	—	-0.03	0.16

Note. AEA = arachidonoylethanolamide; 2-AG = 2-arachidonoylglycerol; VPA = vaginal pulse amplitude; PHYS = non-continuous subjective physiological sexual arousal; MEN = non-continuous mental sexual arousal; OVER = non-continuous overall subjective sexual arousal; CON = continuous subjective sexual arousal.

p < .05

^ˆ

p < .06